Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

10 Approvals To Look Out For In Q3 2023

Jul 20 2023

• By Alexandra Shimmings

• Source: Shutterstock

Related Content

Long Road For Daiichi Sankyo’s Quizartinib Gets Longer As FDA Extends Review Time

Apr 21 2023

Zuranolone Launch Requires Sage To Shift The Way Doctors Treat Depression

Feb 21 2023

Transforming Coherus Adds To IO Pipeline Via Merger With Surface Oncology

Jun 16 2023

Regeneron, Pfizer Tout Potential BCMA Bispecific Advantages At ASCO

Jun 07 2023

Astellas Paying $5.9bn For Iveric To Boost Ophthalmology Presence

May 01 2023

Related Companies

Daiichi Sankyo Co., Ltd.

Coherus Oncology, Inc.

Sage Therapeutics, Inc.

Biogen, Inc.

Galera Therapeutics, Inc.

Swedish Orphan Biovitrum AB

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals Inc.

Iveric Bio, Inc.

Astellas Pharma, Inc.

Apellis Pharmaceuticals, Inc.

Pfizer Inc.

Tarsus Pharmaceuticals Inc.

BioLineRx Ltd.

Novo Nordisk A/S

Dicerna Pharmaceuticals, Inc.

Additional Topics

Approvals Companies Regulation Research & Development Cancer Dermatology Neurology Metabolic Disorders Ophthalmic BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window